Prospective clinical study reveals significant reduction in triglyceride level and white blood cell count after liposuction and abdominoplasty and no change in cholesterol levels

Plastic and Reconstructive Surgery

Volumn 128, Issue 3, 2011, Pages

  Swanson, Eric ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; TRIACYLGLYCEROL;

ABDOMINAL WALL; ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD; BODY MASS; FEMALE; FOLLOW UP; HUMAN; LEUKOCYTE COUNT; LIPECTOMY; MALE; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PLASTIC SURGERY; POSTOPERATIVE COMPLICATION; PROSPECTIVE STUDY;

ABDOMINAL WALL; ADOLESCENT; ADULT; AGED; BODY MASS INDEX; CHOLESTEROL; COMBINED MODALITY THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE COUNT; LIPECTOMY; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; RECONSTRUCTIVE SURGICAL PROCEDURES; TRIGLYCERIDES; YOUNG ADULT;

EID: 80052470150     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e31822213c6     Document Type: Article

References (61)

1. Reaven GM. Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1988;37:1595-1607.
2. Liese AD, Mayer-Davis EJ, Haffner SM. Development of the multiple metabolic syndrome: An epidemiologic perspective. Epidemiol Rev. 1998;20:157-172.
3. Available at: http://www.heart.org/HEARTORG/Conditions/More/ MetabolicSyndrome/About-Metabolic-Syndrome-UCM-301920-Article.jsp. Accessed July 9, 2011.
4. National Cholesterol Education Program. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). National Institutes of Health Publication No. 02-5215. Bethesda, Md: National Institutes of Health, National Heart, Lung, and Blood Institute; 2002.
5. Swanson E. Assessment of reduction in subcutaneous fat thickness after liposuction using magnetic resonance imaging. J Plast Reconstr Aesthet Surg. (in press).
6. Flegal KM, Carroll MD, Ogden CL, Curtin LR. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010;303:235-241.
7. Sackett DL, Straus SE, Richardson WS, Rosenberg W, Haynes RB. Therapy. In: Evidence-Based Medicine. 2nd ed. New York: Churchill Livingstone; 2000:105-154.
8. Samdal F, Birkeland KI, Ose L, Amland PF. Effect of largevolume liposuction on sex hormones and glucose-and lipid metabolism in females. Aesthetic Plast Surg. 1995;19:131-135.
9. Baxter RA. Serum lipid changes following large-volume suction lipectomy. Aesthet Surg J. 1997;17:213-215.
10. González-Ortiz M, Robles-Cervantes JA, Cárdenas-Camarena L, Bustos-Saldaña R, Mart́nez-Abundis E. The effects of surgically removing subcutaneous fat on the metabolic profile and insulin sensitivity in obese women after large-volume liposuction treatment. Horm Metab Res. 2002;34:446-449.
11. Klein S, Fontana L, Young VL, et al. Absence of an effect of liposuction on insulin action and risk factors for coronary heart disease. N Engl J Med. 2004;350:2549-2557.
12. Giese SY, Bulan EJ, Commons GW, Spear SL, Yanovski JA. Improvements in cardiovascular risk profile with large-volume liposuction: A pilot study. Plast Reconstr Surg. 2001;108: 510-519; discussion 520-521.
13. Liszka TG, Dellon AL, Im M, Angel MF, Plotnick L. Effect of lipectomy on growth and development of hyperinsulinemia and hyperlipidemia in the Zucker rat. Plast Reconstr Surg. 1998;102:1122-1127.
14. Robles-Cervantes JA, Yánez-D́az S, Cárdenas-Camarena L. Modification of insulin, glucose and cholesterol levels in nonobese women undergoing liposuction: Is liposuction metabolically safe? Ann Plast Surg. 2004;52:64-67.
15. Vandeweyer E. Does liposuction influence lipidogram in females: In vivo study. Aesthetic Plast Surg. 2002;26:17-19.
16. Ybarra J, Blanco-Vaca F, Fernández S, et al. The effects of liposuction removal of subcutaneous abdominal fat on lipid metabolism are independent of insulin sensitivity in normaloverweight individuals. Obes Surg. 2008;18:408-414.
17. Robles-Cervantes JA, Castillo-Salcedo T, Guerrerosantos J, et al. Behavior of visfatin in nonobese women undergoing liposuction: A pilot study. Aesthet Surg J. 2010;30:730-732.
18. Ross R, Léger L, Morris D, de Guise J, Guardo R. Quantification of adipose tissue by MRI: Relationship with anthropometric variables. J Appl Physiol. 1992;72:787-795.
19. Ross R, Shaw KD, Martel Y, de Guise J, Avruch L. Adipose tissue distribution measured by magnetic resonance imaging in obese women. Am J Clin Nutr. 1993;57:470-475.
20. Kvist H, Chowdhury B, Granga°rd U, Tylén U, Sjöström L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: Predictive equations. Am J Clin Nutr. 1988;48:1351-1361.
21. Schreiber JE, Singh NK, Shermak MA. The effect of liposuction and diet on ghrelin, adiponectin, and leptin levels in obese Zucker rats. Plast Reconstr Surg. 2006;117:1829-1835.
22. Tiikkainen M, Bergholm R, Vehkavaara S, et al. Effects of identical weight loss on body composition and features of insulin resistance in obese women with high and low liver fat content. Diabetes 2003;52:701-707.
23. Goodpaster BH, Kelley DE, Wing RR, Meier A, Thaete FL. Effects of weight loss on regional fat distribution and insulin sensitivity in obesity. Diabetes 1999;48:839-847.
24. Purnell JQ, Kahn SE, Albers JJ, Nevin DN, Brunzell JD, Schwartz RS. Effect of weight loss with reduction of intraabdominal fat on lipid metabolism in older men. J Clin Endocrinol Metab. 2000;85:977-982.
25. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: A meta-analysis. Am J Clin Nutr. 1992;56:320-328.
26. Lemieux S, Prud'homme D, Bouchard C, Tremblay A, Despre ́s JP. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am J Clin Nutr. 1993;58:463-467.
27. Camhi SM, Bray GA, Bouchard C, et al. The relationship of waist circumference and BMI to visceral, subcutaneous, and total body fat: Sex and race differences. Obesity (Silver Spring) 2011;19:402-408.
28. Matarasso A, Kim RW, Kral JG. The impact of liposuction on body fat. Plast Reconstr Surg. 1998;102:1686-1689.
29. Terry RB, Stefanick ML, Haskell WL, Wood PD. Contributions of regional adipose tissue depots to plasma lipoprotein concentrations in overweight men and women: Possible protective effects of thigh fat. Metabolism 1991;40:733-740.
30. Björntorp P. "Portal" adipose tissue as a generator of risk factors for cardiovascular disease and diabetes. Arteriosclerosis 1990;10:493-496.
31. Abate N, Garg A, Peshock RM, Stray-Gunderson J, Grundy SM. Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin Invest. 1995;96:88-98.
32. Havel RJ, Kane JP, Balasse EO, Segel N, Basso LV. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyc-eridemic and hypertriglyceridemic humans. J Clin Invest. 1970;49:2017-2035.
33. Jensen MD. Is visceral fat involved in the pathogenesis of the metabolic syndrome? Human model. Obesity (Silver Spring) 2006;14(Suppl 1):20S-24S.
34. Martin ML, Jensen MD. Effects of body fat distribution on regional lipolysis in obesity. J Clin Invest. 1991;88:609-613.
35. Guo Z, Hensrud DD, Johnson CM, Jensen MD. Regional postprandial fatty acid metabolism in different obesity phenotypes. Diabetes 1999;48:1586-1592.
36. Goodpaster BH, Thaete FL, Simoneau JA, Kelley DE. Subcutaneous abdominal fat and thigh muscle composition predict insulin sensitivity independently of visceral fat. Diabetes 1997;46:1579-1585.
37. Kahn R, Buse J, Ferrannini E, Stern M; American Diabetes Association European Association for the Study of Diabetes. The metabolic syndrome: Time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 2005;28:2289-2304.
38. Kahn R. Metabolic syndrome: What is the clinical usefulness? Lancet 2008;371:1892-1893.
39. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol. 1998;81:7B-12B.
40. Assmann G, Schulte H, Funke H, von Eckardstein A. The emergence of triglycerides as a significant independent risk factor in coronary artery disease. Eur Heart J. 1998;19(Suppl M):M8-M14.
41. Sattar N, McConnachie A, Shaper AG, et al. Can metabolic syndromes usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies. Lancet 2008;371:1927-1935.
42. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab. 2004;89:2548-2556.
43. Esposito K, Giugliano G, Scuderi N, Giugliano D. Role of adipokines in the obesity-inflammation relationship: The effect of fat removal. Plast Reconstr Surg. 2006;118:1048-1057; discussion 1058-1059.
44. Ahima RS, Flier JS. Adipose tissue as an endocrine organ. Trends Endocrinol Metab. 2000;11:327-332.
45. Kern PA, Ranganathan S, Li C, Wood L, Ranganathan G. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. Am J Physiol Endocrinol Metab. 2001;280:E745-E751.
46. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000;148:209-214.
47. Ziccardi P, Nappo F, Giugliano G, et al. Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 2002;105:804-809.
48. Rizzo MR, Paolisso G, Grella R, et al. Is dermolipectomy effective in improving insulin action and lowering inflammatory markers in obese women? Clin Endocrinol (Oxf.) 2005; 63:252-258.
49. Giugliano G, Nicoletti G, Grella E, et al. Effect of liposuction on insulin resistance and vascular inflammatory markers in obese women. Br J Plast Surg. 2004;57:190-194.
50. Bulló M, Garća-Lorda P, Megias I, Salas-Salvadó J. Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res. 2003;11:525-531.
51. Danesh J, Collins R, Appleby P, Peto R. Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: Meta-analyses of prospective studies. JAMA 1998;279:1477-1482.
52. Coller BS. Leukocytosis and ischemic vascular disease morbidity and mortality: Is it time to intervene? Arterioscler Thromb Vasc Biol. 2005;25:658-670.
53. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease. J Am Coll Cardiol. 2004; 44:1945-1956.
54. Stevens VJ, Obarzanek E, Cook NR, et al. Long-term weight loss and changes in blood pressure: Results of the Trials of Hypertension Prevention, phase II. Ann Intern Med. 2001; 134:1-11.
55. Swaminathan R, Major P, Snieder H, Spector T. Serum creatinine and fat-free mass (lean body mass). Clin Chem. 2000; 46:1695-1696.
56. Baxmann AC, Ahmed MS, Marques NC, et al. Influence of muscle mass and physical activity on serum and urinary creatinine and serum cystatin C. Clin J Am Soc Nephrol. 2008;3: 348-354.
57. Haeck PC, Swanson JA, Gutowski KA, et al. Evidence-based patient safety advisory: Liposuction. Plast Reconstr Surg. 2009; 124(Suppl):28S-44S.
58. Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease: The Bezafibrate Infarction Prevention (BIP) study. Circulation 2000;102:21-27.
59. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med. 1999;340:115-126.
60. Brown DW, Giles WH, Croft JB. White blood cell count: An independent predictor of coronary heart disease mortality among a national cohort. J Clin Epidemiol. 2001;54:316-322.
61. Loimaala A, Rontu R, Vuori I, et al. Blood leukocyte count is a risk factor for intima-media thickening and subclinical carotid atherosclerosis in middle-aged men. Atherosclerosis 2006;188:363-369.